Hi
Iontophoresis in Physiotherapy: Mechanism, Physics, Physiology, Indications, Contraindications, Procedure and Research Evidence
Introduction
Iontophoresis is an electrotherapy technique that uses a small, controlled electrical current to assist the movement of ionized medication or other charged substances across the skin.
Unlike TENS or NMES, whose primary purpose is to stimulate nerves or muscles, iontophoresis is primarily a drug-delivery technique.
The basic concept is simple:
Electrical current + charged medication → enhanced movement through the skin
The skin's outermost layer, the stratum corneum, normally acts as a major barrier to the passage of many substances. Iontophoresis uses an electrical potential to increase transport, particularly for hydrophilic and ionizable molecules. The main physical mechanisms include electromigration and electroosmosis.
In physiotherapy, iontophoresis has historically been used to deliver medications such as:
dexamethasone sodium phosphate,
acetic acid,
lidocaine,
and other appropriately formulated ionized substances.
However, the clinical effectiveness of iontophoresis depends on the drug, diagnosis, concentration, electrode polarity, current dose, treatment schedule, and comparator treatment.
Therefore, it is important not to make the assumption that:
"If a medication can be placed under an electrode, it will automatically reach the target tissue in a clinically meaningful amount."
The actual transport and clinical effect are considerably more complex.
What Is Iontophoresis?
Iontophoresis is a form of transdermal drug delivery assisted by electrical current.
A medication containing charged molecules is placed beneath an electrode with the same electrical charge.
The principle is:
Like charges repel.
Therefore:
a negatively charged drug is placed beneath the negative electrode (cathode),
a positively charged drug is placed beneath the positive electrode (anode).
The medication is then driven away from the active electrode and toward the body.
A second electrode, called the dispersive or return electrode, completes the electrical circuit.
This is different from simply putting medication on the skin.
The electrical field actively assists transport across the skin barrier.
Mechanism of Iontophoresis
The mechanism can be understood in several stages.
Stage 1: Medication is placed at the treatment site
The selected ionized medication is incorporated into an appropriate electrode pad, solution, gel, or drug-delivery system.
The drug must have suitable physicochemical properties for electrically assisted transport.
Stage 2: Electrical field is created
The iontophoresis device produces a controlled electrical current between two electrodes.
The treatment electrode contains the medication.
The second electrode provides the return pathway.
Stage 3: Electrical repulsion drives charged molecules
If the medication is negatively charged, the negative electrode repels it.
If the medication is positively charged, the positive electrode repels it.
This is called electromigration.
Electromigration is particularly important for ionized molecules because the electric field directly acts on their charge.
Stage 4: Electroosmosis contributes to transport
Electrical current can also produce movement of solvent through the skin.
This phenomenon is called electroosmosis.
It can contribute to movement of substances across the skin even when the substance itself is not strongly ionized.
Therefore, iontophoresis is not simply "pushing a drug through the skin."
It involves several interacting transport processes.
Stage 5: Drug enters the skin
The medication moves through the skin, primarily using pathways that offer lower resistance to transport.
The stratum corneum contains aqueous pathways and appendageal structures that can contribute to electrically assisted transport.
The amount delivered depends on:
current,
current density,
treatment duration,
drug concentration,
molecular charge,
molecular size,
skin condition,
electrode size,
skin hydration,
and formulation.
Physics Behind Iontophoresis
1. Electric potential difference
Iontophoresis requires an electrical potential difference between two electrodes.
This produces an electric field across the treatment area.
The field provides the driving force for movement of charged particles.
2. Coulombic repulsion
The fundamental concept is electrical repulsion.
A positively charged molecule experiences force away from the positive electrode.
A negatively charged molecule experiences force away from the negative electrode.
This is the basis for choosing the active electrode polarity.
3. Current
Current is the flow of electrical charge.
It is measured in:
Amperes (A)
Physiotherapy iontophoresis generally uses relatively small currents.
Clinically, treatment may be described using mA or, more importantly, mA-minutes.
Current Density
One of the most important concepts in iontophoresis is current density.
Current density describes how much current is applied relative to electrode area.
A simplified relationship is:
Current density = current ÷ electrode area
For example, the same current distributed over a larger electrode produces lower current density than when it is concentrated over a smaller electrode.
This matters because excessive current density increases the risk of:
skin irritation,
burning,
erythema,
pain,
and chemical skin injury.
Research on iontophoresis has repeatedly identified current density and total current exposure as important factors in skin reactions.
mA-Minutes
Iontophoresis is often dosed using:
mA-minutes
The calculation is:
mA × treatment time in minutes = mA-minutes
For example:
4 mA × 10 minutes = 40 mA-minutes
Another treatment could theoretically use:
2 mA × 20 minutes = 40 mA-minutes
Both deliver the same total mA-minutes, but they do not necessarily produce identical tissue or skin responses, because current density, electrode size, treatment duration, drug formulation, and tissue conditions also matter.
Therefore, mA-minutes are useful for documentation but do not completely describe the biological dose.
Electrical Resistance of Skin
The skin is not an equally conductive material throughout its thickness.
The stratum corneum provides substantial resistance to electrical and molecular transport.
Hydration, temperature, skin thickness, electrode contact, and skin condition can change electrical resistance.
When electrical current is applied, current tends to preferentially travel through pathways that provide less resistance.
This helps explain why electrode contact and skin preparation are clinically important.
Electrode Polarity
Correct polarity is essential.
Positive medication ion
Use the positive electrode to repel a positively charged medication.
Negative medication ion
Use the negative electrode to repel a negatively charged medication.
A simple memory aid is:
"Like repels like."
The drug is placed under the electrode with the same charge.
Physiology of Iontophoresis
Iontophoresis does not primarily stimulate muscle or sensory nerves in the same way as NMES or TENS.
Its main physiological purpose is to modify drug delivery through the skin.
The subsequent physiological effect depends largely on the medication being delivered.
For example, if an anti-inflammatory medication is delivered, any anti-inflammatory effect comes primarily from the pharmacological action of that medication rather than from the electrical current itself.
This distinction is clinically important.
Skin Barrier and Drug Transport
The stratum corneum is highly effective at limiting penetration of many substances.
This is useful physiologically because the skin protects the body from the external environment.
However, it creates a challenge for transdermal drug delivery.
Iontophoresis provides an external driving force that can increase the transport of charged and hydrophilic substances.
Local vs Systemic Drug Delivery
Physiotherapists often use iontophoresis with the goal of producing a local effect near the treatment area.
However, it is important not to assume that all of the medication remains precisely at the tissue beneath the electrode.
Some drug can:
remain within the skin,
enter deeper tissues,
be transported away,
or potentially enter systemic circulation.
The amount depends on the drug and treatment conditions.
Therefore, iontophoresis should still be considered a drug-delivery procedure, with the medication's pharmacology and contraindications taken seriously.
How the Iontophoresis Machine Works
A modern iontophoresis unit generally contains:
Power source
Current generator
Current-control circuitry
Polarity control
Intensity adjustment
Treatment timer
Electrode connections
Drug-delivery electrode
Dispersive electrode
Safety monitoring features
The clinician selects the appropriate polarity and current intensity.
The machine then delivers controlled direct current through the treatment electrodes.
Simplified pathway
Machine → electrode → skin → treatment area → return electrode → machine
The medication is placed beneath the appropriate active electrode.
Types of Iontophoresis Devices
1. Conventional clinic-based iontophoresis
These systems are used in physiotherapy clinics and allow the clinician to control:
current,
polarity,
treatment duration,
and sometimes total mA-minutes.
2. Disposable iontophoresis patches
Some systems contain a medication reservoir and a small integrated battery.
These devices can provide treatment without a large clinic-based machine.
Research has investigated dexamethasone iontophoresis delivered through self-contained patches in conditions such as lateral epicondylitis.
Indications
The exact indications depend on the medication and diagnosis.
Iontophoresis should not be considered a diagnosis-independent treatment.
1. Localized musculoskeletal pain
Iontophoresis has been investigated for localized musculoskeletal conditions where medication delivery is intended to influence pain or inflammation.
2. Tendinopathies
It has been studied in conditions including:
lateral epicondylitis,
plantar fasciitis,
and other localized tendon-related disorders.
Evidence is mixed and often suggests that benefits are short-term or comparable to other treatments.
3. Lateral epicondylitis
Dexamethasone iontophoresis has been studied extensively in tennis elbow.
A randomized controlled trial of 199 patients found greater short-term improvement in pain with dexamethasone iontophoresis than placebo, but the difference in global improvement was no longer significant at one month.
Another randomized study comparing dexamethasone iontophoresis with placebo/galvanic treatment found improvements in pain, grip strength, and function, with some outcomes favoring iontophoresis.
However, these results should be interpreted within the broader rehabilitation context rather than as evidence that medication delivery alone resolves tendinopathy.
4. Plantar fasciitis
Iontophoresis has also been investigated for plantar fasciitis.
An older randomized placebo-controlled study found greater immediate improvement when dexamethasone iontophoresis was added to traditional modalities, but the difference was no longer significant one month after treatment.
A more recent randomized trial involving 127 patients compared iontophoresis using lidocaine/dexamethasone with radial shockwave therapy. Shockwave therapy produced greater short-term improvements in some outcomes, although both groups experienced pain improvement over follow-up.
5. Local inflammatory conditions
Selected anti-inflammatory medications may be delivered using iontophoresis when clinically appropriate.
The appropriateness depends on:
the diagnosis,
medication,
skin condition,
medical history,
drug contraindications,
and local regulations.
6. Hyperhidrosis
Iontophoresis has a well-established application in the treatment of hyperhidrosis, particularly excessive sweating of the hands and feet.
In this context, the goal is not drug delivery but modification of sweat gland activity through electrical current.
Therefore, the term "iontophoresis" encompasses applications beyond medication delivery.
Contraindications
Contraindications depend on the medication, electrode location, current, and patient.
Because iontophoresis involves both electrical current and medication, both sets of contraindications must be considered.
1. Medication allergy
Do not deliver a medication to which the patient has a known allergy.
This is one of the most important differences between iontophoresis and non-drug electrical stimulation.
2. Medication-specific contraindications
The medication's own contraindications apply.
For example, if corticosteroid iontophoresis is being considered, the clinician must consider corticosteroid-specific precautions.
The fact that a medication is delivered through the skin does not eliminate its pharmacological risks.
3. Broken skin
Avoid electrode application over:
open wounds,
significant skin breakdown,
active ulcers,
or severely damaged skin.
Damaged skin may alter current distribution and increase the risk of irritation or injury.
4. Skin infection
Avoid treatment over active infection unless specifically indicated under an appropriate medical protocol.
5. Impaired sensation
Reduced sensation can make it difficult for the patient to recognize excessive irritation, burning, or pain.
6. Implanted electronic devices
Electrical stimulation precautions should be considered for patients with:
pacemakers,
implanted cardiac defibrillators,
neurostimulators,
or other electronic implants.
The exact risk depends on device type and treatment location.
7. Metal allergy or sensitivity
This becomes particularly important when electrode materials or medication formulations contain components to which the patient reacts.
8. Pregnancy
Appropriate medical assessment is required before iontophoresis during pregnancy, particularly for treatment near the abdomen or pelvis.
9. Malignancy
Avoid inappropriate treatment over known or suspected malignant tissue unless specifically directed within an appropriate oncology treatment plan.
10. Thrombosis
Avoid inappropriate electrical treatment over active thrombosis or thrombophlebitis.
11. Significant vascular impairment
Poor circulation may increase the risk of skin complications.
12. Inability to communicate symptoms
A patient should be able to communicate discomfort or abnormal sensations during treatment.
Procedure: How Iontophoresis Is Applied
Step 1: Clinical assessment
First identify:
diagnosis,
treatment objective,
medication,
medication charge,
contraindications,
skin status,
sensation,
circulation,
allergies,
and relevant medical history.
Step 2: Select the medication
The medication must be:
clinically appropriate,
compatible with iontophoresis,
correctly charged,
correctly formulated,
and used according to applicable prescribing and professional requirements.
The physiotherapist should not assume that any topical medication can safely be placed beneath an electrode.
Step 3: Determine polarity
Identify the medication's electrical charge.
Then select the electrode with the same polarity.
Example
If the medication is negatively charged:
Negative medication → negative active electrode
The negative electrode repels the medication.
Step 4: Prepare the skin
Inspect the treatment area.
Clean the skin according to the device and medication protocol.
Remove excessive oils, lotions, and contaminants that may interfere with electrode contact.
Do not aggressively abrade the skin unless specifically required by an appropriate protocol.
Step 5: Prepare electrodes
One electrode acts as the:
Active/drug electrode
The other acts as the:
Dispersive/return electrode
The active electrode contains the medication.
Step 6: Position the electrodes
Place the active electrode over or near the intended treatment region.
Place the dispersive electrode at an appropriate location to complete the circuit while maintaining safe current distribution.
The electrodes should have good, even contact with the skin.
Step 7: Check the circuit
Before increasing current, ensure:
electrode contact is adequate,
cables are connected correctly,
polarity is correct,
the medication is in the correct electrode,
and the patient understands what they should feel.
Step 8: Start with low intensity
Begin with a low current.
Gradually increase according to:
patient tolerance,
electrode size,
current density,
treatment protocol,
and device instructions.
The patient may feel:
mild tingling,
warmth,
or a slight prickling sensation.
Iontophoresis should not be treated as a test of how much discomfort the patient can tolerate.
Step 9: Monitor the patient
Monitor:
skin sensation,
pain,
burning,
excessive redness,
itching,
discomfort,
and electrode contact.
Stop treatment if significant adverse symptoms develop.
Step 10: Complete the prescribed dose
Treatment duration depends on the protocol.
The clinician may document:
current intensity,
treatment duration,
total mA-minutes,
medication,
concentration,
polarity,
electrode size,
treatment site,
and patient response.
Step 11: Remove electrodes and inspect skin
After treatment:
Turn the current down to zero.
Switch off the device.
Remove electrodes carefully.
Inspect the skin.
Document the patient's response.
Mild transient erythema can occur, but significant burning, blistering, or prolonged skin irritation requires appropriate assessment.
Important Treatment Parameters
There is no universal iontophoresis prescription.
Parameters include:
| Parameter | Why it matters |
|---|---|
| Medication | Determines pharmacological effect and polarity |
| Drug concentration | Influences available drug for transport |
| Drug charge | Determines active electrode polarity |
| Current intensity | Determines electrical dose |
| Electrode area | Determines current density |
| Treatment time | Influences total current exposure |
| mA-minutes | Describes cumulative current dose |
| Skin condition | Affects resistance and safety |
| Electrode placement | Influences current pathway |
| Medication formulation | Influences transport |
| Patient tolerance | Determines safe application |
The relationship between these variables is complex. Drug transport depends not only on current but also on formulation, molecular properties, skin characteristics, and the relative contribution of electromigration and electroosmosis.
Research Evidence
1. Dexamethasone iontophoresis for lateral epicondylitis
One of the classic randomized double-blind placebo-controlled studies included 199 patients with medial or lateral epicondylitis.
Patients received six iontophoresis sessions using 40 mA-minutes of either active dexamethasone or placebo treatment.
Dexamethasone produced greater short-term pain improvement than placebo at two days. At one month, however, the difference in global improvement was no longer statistically significant.
Clinical interpretation
This supports the possibility of a short-term benefit, but does not establish durable superiority.
2. Lateral epicondylitis randomized trial
A later randomized double-blind trial involving 24 patients compared dexamethasone iontophoresis with galvanic current.
Both groups improved in pain, grip strength, and function.
The iontophoresis group demonstrated superior results for some pain and function outcomes.
Limitation
The sample was small, so the findings should not be treated as definitive evidence for all patients with tennis elbow.
3. Iontophoresis vs corticosteroid injection
A randomized study of 82 patients with lateral epicondylitis compared corticosteroid iontophoresis with corticosteroid injections while all participants received the same hand therapy program.
The iontophoresis group showed short-term improvements in grip strength and unrestricted return to work.
By six months, however, the groups had equivalent outcomes.
Clinical meaning
This is an important finding.
Iontophoresis may offer a less invasive method of delivering corticosteroid, but the evidence does not demonstrate a persistent long-term advantage over injection.
4. Plantar fasciitis
An older randomized double-blind trial examined dexamethasone iontophoresis added to traditional treatment.
The iontophoresis group demonstrated greater improvement immediately after treatment, but the difference disappeared at one-month follow-up.
This again suggests that iontophoresis may have short-term symptomatic effects without necessarily changing the longer-term course.
5. Iontophoresis vs shockwave therapy for plantar fasciitis
A 2024 randomized controlled trial involving 127 patients compared iontophoresis with radial shockwave therapy.
The shockwave group showed greater improvement in some short-term outcomes, including pain and plantar fascia thickness, while both groups reported satisfactory improvement.
This illustrates an important principle:
Iontophoresis should be compared with realistic alternatives rather than judged only against no treatment.
6. Carpal tunnel syndrome
A double-blind randomized controlled trial investigated dexamethasone iontophoresis in 17 patients with carpal tunnel syndrome.
Most objective outcome measures did not demonstrate significant treatment-related improvement.
Subjective symptom improvement was observed, but similar improvement occurred in the control group.
Clinical interpretation
This provides an example where the biological rationale for iontophoresis does not automatically translate into strong clinical evidence.
What Does the Broader Evidence Tell Us?
A review specifically examining dexamethasone iontophoresis for musculoskeletal conditions concluded that interpretation was difficult because many studies combined iontophoresis with other treatments. This makes it challenging to isolate the effect of the iontophoresis itself.
This is a recurring issue in electrotherapy research.
For example:
Iontophoresis + exercise + manual therapy + education
may outperform:
placebo iontophoresis + exercise + manual therapy + education
but the additional benefit cannot automatically be attributed entirely to the electrical drug delivery.
Evidence-Based Clinical Practice Analysis
What is well established?
The physical mechanism of iontophoresis is well established.
Electrical current can enhance transport of appropriately charged substances through the skin.
The mechanisms of electromigration and electroosmosis are supported by experimental pharmacology and transdermal drug-delivery research.
What is less certain?
The key clinical question is:
Does delivering a particular medication by iontophoresis produce a meaningful patient benefit for a particular diagnosis?
The answer varies.
Evidence is stronger for some short-term symptomatic outcomes than for long-term disease modification.
Mechanism Is Not the Same as Clinical Effectiveness
This distinction is extremely important.
Mechanistic evidence
Shows that:
Current can move charged molecules across skin.
Clinical evidence
Must answer:
Does this improve pain, function, strength, disability, recovery, or quality of life in patients with a particular condition?
A scientifically convincing mechanism does not automatically prove clinical effectiveness.
Iontophoresis and Exercise Therapy
For many musculoskeletal conditions, exercise remains an important component of rehabilitation.
For example, in tendinopathy or plantar heel pain, a clinician may use:
education,
load management,
strengthening,
progressive exercise,
movement retraining,
and functional rehabilitation.
Iontophoresis, when appropriate, may be used as an adjunct to manage symptoms rather than as the entire treatment.
This approach also helps avoid overreliance on passive modalities.
Advantages of Iontophoresis
1. Non-invasive drug delivery
It can deliver medication through the skin without an injection.
2. Local treatment
The treatment can be targeted to a relatively small area.
3. Avoids a needle
This may be attractive to patients who prefer non-invasive treatment.
4. Controlled electrical dose
The clinician can control current intensity and duration.
5. Can be combined with rehabilitation
It can be used alongside exercise and other appropriate interventions.
Limitations
1. Drug delivery is variable
The amount reaching deeper tissue can vary substantially.
2. Skin reactions
Iontophoresis can produce:
redness,
irritation,
burning,
dryness,
itching,
or skin injury.
Current density and total current exposure are important contributors.
3. Medication limitations
Not every medication is suitable for iontophoresis.
4. Evidence varies by diagnosis
Positive evidence in one condition cannot automatically be transferred to another.
5. Short-term benefits may not persist
Several clinical trials demonstrate short-term improvements that become less distinct over longer follow-up.
Common Clinical Mistakes
Mistake 1: Wrong electrode polarity
This is one of the fundamental errors.
Remember:
Like charges repel.
Mistake 2: Treating the electrode size as unimportant
Electrode area affects current density.
The same current through a smaller electrode can create substantially greater current density.
Mistake 3: Assuming higher current is better
More current is not automatically better drug delivery.
Higher current can increase discomfort and skin injury.
Mistake 4: Ignoring the medication's contraindications
Iontophoresis does not make a contraindicated medication safe.
Mistake 5: Treating every topical medication as iontophoresis-compatible
A medication needs appropriate physicochemical properties and a clinically appropriate formulation.
Mistake 6: Calling all skin redness a normal response
Mild transient erythema can occur, but significant burning, blistering, or persistent irritation requires attention.
Mistake 7: Using iontophoresis without reassessment
Treatment should be linked to a measurable clinical goal.
Ask:
Did pain improve?
Did function improve?
Did range of motion change?
Did exercise tolerance improve?
Did the patient return to activity?
Myths and Facts
Myth: Iontophoresis pushes medication directly into the muscle.
Fact: It enhances transdermal transport. The amount and depth of drug delivery depend on the drug, formulation, current, skin properties, and treatment conditions.
Myth: The drug stays exactly under the electrode.
Fact: Drug transport is dynamic and can involve movement through skin pathways, diffusion, electromigration, and electroosmosis.
Myth: More current means more medication delivery.
Fact: Increasing current can increase transport under some conditions, but it can also increase skin irritation and injury. Current density and formulation matter.
Myth: Iontophoresis is completely side-effect free because it is non-invasive.
Fact: Non-invasive does not mean risk-free. Skin irritation and medication-related adverse effects remain possible.
Myth: Iontophoresis replaces exercise for tendinopathy.
Fact: It may be an adjunct for symptom management, but rehabilitation should address loading capacity, strength, function, and the underlying clinical problem.
Myth: Every iontophoresis treatment uses dexamethasone.
Fact: Dexamethasone is commonly studied, but the appropriate medication depends on the clinical indication and professional/medical requirements.
Frequently Asked Questions
Does iontophoresis hurt?
Most patients describe mild tingling or prickling. Excessive current can become uncomfortable or cause skin irritation.
How long does iontophoresis take?
Treatment duration varies according to the device, medication, current, electrode size, and prescribed dose.
What medication is most commonly used?
Dexamethasone sodium phosphate is one of the best-studied medications in musculoskeletal iontophoresis, but medication selection must be clinically appropriate.
Does iontophoresis work for tennis elbow?
Some trials show short-term improvements in pain, grip strength, or function, but long-term superiority is less clear.
Does iontophoresis work for plantar fasciitis?
Some evidence supports short-term improvement, but longer-term differences are less consistent.
Can iontophoresis replace an injection?
It can provide a non-invasive alternative for some medication-delivery applications, but it should not automatically be considered equivalent to injection for every condition.
Can iontophoresis be used with broken skin?
Generally, treatment should not be applied over open or significantly damaged skin because current distribution and skin injury risk can be altered.
Is iontophoresis the same as TENS?
No.
TENS primarily uses electrical stimulation to influence pain perception.
Iontophoresis primarily uses electrical current to assist transdermal transport of a substance.
Evidence-Based Takeaway
Iontophoresis is best understood as electrically assisted transdermal delivery, not simply another form of pain-relieving electrical stimulation.
Its core mechanism involves:
Electrical field → electromigration + electroosmosis → enhanced transdermal transport
The physics of ion transport is well established.
The clinical effectiveness, however, is condition- and medication-specific.
For some musculoskeletal conditions, particularly lateral epicondylitis and plantar fasciitis, research has demonstrated short-term improvements with certain protocols. However, several studies show that these effects may diminish with longer follow-up, and evidence quality varies.
Therefore, evidence-based physiotherapy should use iontophoresis selectively and evaluate it according to meaningful patient outcomes rather than assuming that successful drug delivery automatically equals successful rehabilitation.
Conclusion
Iontophoresis is a fascinating physiotherapy modality because it combines electrophysics, skin physiology, pharmacology, and rehabilitation.
Its fundamental principle is straightforward:
A controlled electrical field can assist the movement of appropriately charged substances through the skin.
But effective clinical use requires much more than placing medication beneath an electrode.
The clinician must understand:
drug charge,
electrode polarity,
current density,
mA-minutes,
skin resistance,
drug formulation,
medication contraindications,
patient sensation,
electrode placement,
treatment duration,
and the evidence for the specific diagnosis.
The most appropriate clinical mindset is therefore:
Use iontophoresis when there is a clear therapeutic rationale for electrically assisted drug delivery, monitor safety carefully, and integrate it with active rehabilitation rather than treating the modality as a standalone cure.
Selected References
Wang Y, Zeng L, Song W, Liu J. Influencing factors and drug application of iontophoresis in transdermal drug delivery. Drug Delivery and Translational Research. PMID: 33486687.
Srinivasan V, Higuchi WI, Sims SM, Ghanem AH, Behl CR. Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery. PMID: 2664125.
Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Advanced Drug Delivery Reviews. PMID: 15019750.
Kalia YN et al. Mechanistic aspects of iontophoresis in human epidermal membrane. PMID: 10518630.
Iontophoretic transport across the skin. PMID: 11509905.
Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis: randomized, double-blind, placebo-controlled study. PMID: 12642251.
Iontophoresis in lateral epicondylitis: randomized, double-blind clinical trial. PMID: 31447123.
Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone: randomized, double-blind, placebo-controlled study. PMID: 9167809.
Comparison of short-term effect between iontophoresis and radial extracorporeal shockwave therapy in plantar fasciitis. PMID: 38921337.
Corticosteroid iontophoresis to treat carpal tunnel syndrome: double-blind randomized controlled trial. PMID: 19347928.
A randomized study comparing corticosteroid injection to corticosteroid iontophoresis for lateral epicondylitis. PMID: 22196293.
The effect of dexamethasone iontophoresis on decreasing pain and improving function in patients with musculoskeletal conditions. PMID: 25203304.
Eker Büyükşireci D, Büyükşireci M, Komut E. Evaluation of dexamethasone iontophoresis, galvanic current, and conservative treatment in knee osteoarthritis with Baker's cyst. PMID: 36589359.
Clinical note: Iontophoresis involves both an electrical treatment and a medication. Medication selection, prescribing authority, contraindications, formulation, and device-specific instructions vary by country and clinical setting. The actual treatment should therefore follow applicable professional regulations, manufacturer instructions, and individualized clinical assessment.
